General Information of the Compound
Compound ID
CP0029321
Compound Name
PF-6305591
    Show/Hide
Synonyms
PF-06305591
    Show/Hide
Structure
Formula
C15H22N4O
Molecular Weight
274.368
Canonical SMILES
C[C@H]([C@H](N)c1nc2ccc(cc2[nH]1)C(C)(C)C)C(N)=O
    Show/Hide
InChI
InChI=1S/C15H22N4O/c1-8(13(17)20)12(16)14-18-10-6-5-9(15(2,3)4)7-11(10)19-14/h5-8,12H,16H2,1-4H3,(H2,17,20)(H,18,19)/t8-,12+/m1/s1
    Show/Hide
InChIKey
APWZIFIAVVFPNT-PELKAZGASA-N
CAS
1449473-97-5
Physicochemical Property
logP
1.9816
Rotatable Bonds
3
Heavy Atom Count
20
Polar Areas
97.79
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
3
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71666749
ChEMBL ID
CHEMBL4297317
DrugBank ID
DB12106
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02752, Sodium channel protein type 10 subunit alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PF-06305591 )
Drug Name PF-06305591
Company Pfizer
Indication
Chronic pain
Phase 1